University of California, Irvine
Mahtab Jafri
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Chronic Myeloid Leukemia
Chronic Phase Chronic Myelogenous Leukemia
Interview
The purpose of this pilot study is to explore the association between personality and adherence to a specific type of oral cancer medication - tyrosine kinase inhibitor (TKI) - in patients with chronic myeloid leukemia (CML). 75 individuals with chronic phase CML who are being treated with TKIs will be recruited. Consenting patients will participate in a focused interview where TKI adherence, personality type, and quality of life and symptom burden will be assessed using validated questionnaires. Information on treatment response and the treating physician's perception of TKI adherence will be obtained from the electronic health record.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 75 participants |
| Official Title : | Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia |
| Actual Study Start Date : | 2024-01-25 |
| Estimated Primary Completion Date : | 2025-12-31 |
| Estimated Study Completion Date : | 2026-01 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Chao Family Comprehensive Cancer Center University of California, Irvine
Orange, California, United States, 92868